Attached files

                                  EXHIBIT 32.1

                     CERTIFICATION OF DISCLOSURE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of  CannaPharmaRX,  Inc. (the "Company")
on Form  10-Q  for the  period  ending  September  30,  2014 as  filed  with the
Securities  and Exchange  Commission on the date hereof (the  "Report") I, Gerry
Crocker,  Chief  Executive  Officer  and  Principal  Executive  Officer,  of the
Company,  certify,  pursuant  to 18 USC  section  1350,  as adopted  pursuant to
Section 906 of the  Sarbanes-Oxley Act of 2002, that to the best of my knowledge
and belief:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


Dated: November 19, 2014


/s/ Gerry Crocker
-----------------------------------------------------------------------
Gerry Crocker (Chief Executive Officer and Principal Executive Officer)


This  certification  accompanies  the  Report  pursuant  to  Section  906 of the
Sarbanes-Oxley  Act of 2002 and shall not,  except to the extent required by the
Sarbanes-Oxley  Act of 2002,  be deemed  filed by the  Company  for  purposes of
Section 18 of the Securities Exchange Act of 1934, as amended